Co-investors include Genoa Ventures, Bpifrance, Casdin Capital and Alexandria Venture Investments

Fixx Pharmaceuticals founder, Jesse John Francis Clark, responds to recent report stating that human embryo gene editing isn't safe, yet.

Fixx Pharmaceuticals was founded by Jesse John Francis Clark - a man dedicated to improving the lives of those suffering from bleeding disorders.

The co-inventor of CRISPR genome editing technology expands research collaborations to San Francisco's Mission Bay research community

GenScript CRISPR service to deliver precise custom edited yeast strains in as few as 5 weeks

Company to offer first CRISPR-based custom genome editing service for yeast strains